| Date of start of reporting period | 01/04/2023 |
| Date of end of reporting period | 31/03/2024 |
| Whether accounts are audited or unaudited | Audited |
|
| OPERATING RESULTS | | |
| 1 | Operating income | |
| (i) | Gross Premiums Written | 255,941.60 |
| (ii) | Net Premium written | 181,656.10 |
| (iii) | Premium Earned (Net) | 168,664.70 |
| (iv) | Income from investments (net) | 27,760.60 |
| (v) | Other income | |
| i | Foreign exchange gain / (loss) | 107.30 |
| ii | Investment income from pool (Terrorism / Nuclear) | 844.00 |
| iii | Contribution from Shareholders Funds towards excess EOM | 0.00 |
| iv | Miscellaneous Income | 144.50 |
| Total other income | 1,095.80 |
| (vi) | Total income | 197,521.10 |
| 2 | Operating expenses | |
| (i) | Commissions & Brokerage (net) | 30,890.10 |
| (ii) | Net commission | 30,890.10 |
| (iii) | Operating Expenses related to insurance business | |
| (a) | Employees remuneration and welfare expenses | 12,562.20 |
| (b) | Other operating expenses | |
| i | Advertisement and publicity | 1,523.60 |
| ii | Sales promotion | 4,345.90 |
| iii | Other expenses | 9,745.60 |
| Total other operating expenses | 15,615.10 |
| (c) | Total operating expenses related to insurance business | 28,177.30 |
| (iv) | Premium Deficiency | 0.00 |
| (v) | Incurred Claims | |
| (a) | Claims Paid | 100,189.30 |
| (b) | Change in Outstanding Claims (incl. IBNR/IBNER) | 19,205.40 |
| Total Incurred claims | 119,394.70 |
| (vi) | Total Expense | 178,462.10 |
| (vii) | Underwriting Profit(Loss) | -9,797.40 |
| (viii) | Provisions for doubtful debts (including bad debts written off) | 0.00 |
| (ix) | Provisions for diminution in value of investments | 0.00 |
| (x) | Operating Profit/loss: | 19,059.00 |
| (xi) | Appropriations | |
| (a) | Transfer to Profit and Loss A/c | 19,059.00 |
| (b) | Transfer to reserves | 0.00 |
| | |
| NON-OPERATING RESULTS | | |
| 1 | Income in shareholders’ account | |
| (a) | Transfer from Policyholders Fund | 19,059.00 |
| (b) | Income from investments | 8,448.40 |
| (c) | Other income | |
| i | Other income | 51.70 |
| Total other income | 51.70 |
| Total income | 27,559.10 |
| 2 | Expenses | |
| (i) | Expenses other than those related to insurance business | 607.90 |
| (ii) | Provisions for doubtful debts (including bad debts written off) | 441.20 |
| (iii) | Provisions for diminution in value of investments | 958.20 |
| Total Expense | 2,007.30 |
| 3 | Profit / Loss before extraordinary items | 25,551.80 |
| 4 | Extraordinary Items | 0.00 |
| 5 | Profit/ (loss) before tax | 25,551.80 |
| 6 | Provision for tax | 6,365.90 |
| 7 | Profit / (loss) after tax | 19,185.90 |
| 8 | Divident per share | |
| (a) | Interim Dividend | 0.50 |
| (b) | Final dividend | 0.55 |
| 9 | Opening Balance and Approproations from PAT (Net) | 29,001.70 |
| 10 | Profit (loss) carried to balance sheet | 48,187.70 |
| 11 | Paid up equity capital | 4,926.90 |
| 12 | Reserve and Surplus (Excluding Revaluation Reserve) | 114,670.90 |
| 13 | Fair value change account and revaluation reserve | 9,895.50 |
| 14 | Assets | |
| (a) | Investments | |
| (i) | Shareholders Fund | 115,868.60 |
| (ii) | Policyholders Fund | 373,203.80 |
| Total investments | 489,072.40 |
| (b) | Other Assets (Net of current liabilities and provisions) | -359,222.10 |
| Total assets | 129,850.30 |
| | |
| Analytical Ratios | | |
| (i) | Solvency ratio | 2.62 |
| (ii) | Expenses of management ratio | 29.80 |
| (iii) | Incurred Claim Ratio | 70.80 |
| (iv) | Net retention ratio | 71.00 |
| (v) | Combined ratio | 103.30 |
| (vi) | Earning per share | |
| (a) | Basic and diluated EPS before extraordinary items (net of tax expense) for the period (not to be annualized) | 39.03 |
| (b) | Basic and diluted EPS after extraordinary items (net of tax expense) for the period (not to be annualized) | 39.03 |
| (vii) | NPA ratios | |
| (a) | Gross NPAs | 0.00 |
| (c) | Net NPAs | 0.00 |
| (b) | Percentage of Gross NPAs | 0.00 |
| (d) | Percentage of net NPAs | 0.00 |
| (viii) | Yield on Investments | |
| (a) | Without unrealized gains | 7.98 |
| (b) | With unrealised gains | 11.16 |
| (ix) | Public shareholding (in case of public sector insurance companies) | |
| (a) | Number of shares | 240,088,167.00 |
| (b) | Percentage of shareholding | 48.73 |
| (c) | Percentage of government holding | 0.00 |
| | |
| | |
| Investor Complaints | | |
| (i) | No of investor complaints pending at the beginning of the period | 0.00 |
| (ii) | No of investor complaints during the period | 0.00 |
| (iii) | No of investor complaints disposed off during the period | 0.00 |
| (iv) | No of investor complaints remaining unresolved at the end of the period | 0.00 |
| | |
| (c) | Notes Format for financial results by general insurance companies filed with stock exchanges | |